Trial intelligence / Profile preview

POISE-2 Pilot

NCT00860925Phase 4Completed

Sponsor
McMaster University
Start
May 2009
Primary completion
Dec 2009
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 4 trial of aspirin, clonidine in cardiovascular disease (CVD), myocardial infarction (MI), sponsored by McMaster University. Started May 2009; status: completed.

02

Drugs

aspirinclonidine
03

Conditions

cardiovascular disease (CVD)myocardial infarction (MI)

Beyond the preview

Go deeper on NCT00860925.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00860925.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call